Sequenom Gains 20% on Down’s Syndrome Discovery
Jun 4th, 2008 | By J. Christoph Amberger | Category: Stock Market InvestingShares of biotech smallcap Sequenom, Inc. (Nasdaq:SQNM) soared over 20% in morning trading after the genetics and molecular diagnostic company reported that its nucleic acid technology is able to detect Down’s syndrome in pregnant women.